Table 5: Results of sensitivity and subgroup analyses.

Efficacy (AL change)Acceptability (dropout rate)
Number of studiesPooled WMD and 95% CI Heterogeneity valueNumber of studiesPooled OR and 95% CIHeterogeneity value

Standard analysis8−0.255 [−0.298, −0.212]0.88560.794 [0.516, 1.222]0.320
 Randomized2−0.282 [−0.379, −0.185]0.66421.400 [0.722, 2.713]1.000
 Nonrandomized6−0.248 [−0.296, −0.200]0.78840.510 [0.281, 0.923]0.786
 Prospective6−0.251 [−0.299, −0.203]0.78460.794 [0.516, 1.222]0.320
 Nested2−0.272 [−0.371, −0.172]0.523
 Asian6−0.254 [−0.301, −0.207]0.81450.856 [0.546, 1.341]0.330
 Caucasian2−0.258 [−0.369, −0.148]0.38810.323 [0.060, 1.726]1.000
 A-Scan2−0.272 [−0.371, −0.172]0.523
 IOLMaster6−0.251 [−0.299, −0.203]0.78460.794 [0.516, 1.222]0.320
 OK versus SV5−0.239 [−0.287, −0.191]0.94640.774 [0.442, 1.355]0.303
 OK versus SC1−0.320 [−0.499, −0.141]1.000
 PRok versus SV1−0.320 [−0.517, −0.123]1.00010.794 [0.186, 1.302]1.000
 Tok versus SV1−0.330 [−0.485, −0.175]1.00011.400 [0.527, 3.718]1.000

WMD = weighted mean difference; CI = credible intervals; AL = axial length; OR = odds ratio.